Changyow C Kwan1, Amani A Fawzi2. 1. Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, 645 N. Michigan Avenue, Suite 440, Chicago, IL, 60611, USA. 2. Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, 645 N. Michigan Avenue, Suite 440, Chicago, IL, 60611, USA. afawzimd@gmail.com.
Abstract
PURPOSE OF REVIEW: Diabetic retinopathy (DR) is the leading cause of acquired vision loss in adults across the globe. Early identification and treatment of patients with DR is paramount for vision preservation. The aim of this review paper is to outline current and new imaging techniques and biomarkers that are valuable for clinical diagnosis and management of DR. RECENT FINDINGS: Ultrawide field imaging and automated deep learning algorithms are recent advancements on traditional fundus photography and fluorescein angiography. Optical coherence tomography (OCT) and OCT angiography are techniques that image retinal anatomy and vasculature and OCT is routinely used to monitor response to treatment. Many circulating, vitreous, and genetic biomarkers have been studied to facilitate disease detection and development of new treatments. Recent advancements in retinal imaging and identification of promising new biomarkers for DR have the potential to increase detection, risk stratification, and treatment for patients with DR.
PURPOSE OF REVIEW: Diabetic retinopathy (DR) is the leading cause of acquired vision loss in adults across the globe. Early identification and treatment of patients with DR is paramount for vision preservation. The aim of this review paper is to outline current and new imaging techniques and biomarkers that are valuable for clinical diagnosis and management of DR. RECENT FINDINGS: Ultrawide field imaging and automated deep learning algorithms are recent advancements on traditional fundus photography and fluorescein angiography. Optical coherence tomography (OCT) and OCT angiography are techniques that image retinal anatomy and vasculature and OCT is routinely used to monitor response to treatment. Many circulating, vitreous, and genetic biomarkers have been studied to facilitate disease detection and development of new treatments. Recent advancements in retinal imaging and identification of promising new biomarkers for DR have the potential to increase detection, risk stratification, and treatment for patients with DR.
Authors: A Yasin Alibhai; Eric M Moult; Rida Shahzad; Carl B Rebhun; Carlos Moreira-Neto; Mitchell McGowan; Diane Lee; Byungkun Lee; Caroline R Baumal; Andre J Witkin; Elias Reichel; Jay S Duker; James G Fujimoto; Nadia K Waheed Journal: Ophthalmol Retina Date: 2017-11-07
Authors: Carmel M McVicar; Micheal Ward; Liza M Colhoun; Jasenka Guduric-Fuchs; Angelika Bierhaus; Thomas Fleming; Andreas Schlotterer; Matthias Kolibabka; Hans-Peter Hammes; Mei Chen; Alan W Stitt Journal: Diabetologia Date: 2015-02-17 Impact factor: 10.122
Authors: Supriya Dabir; Mohan Rajan; Liji Parasseril; Vaidehi Bhatt; Preetam Samant; C A B Webers; T T J M Berendschot Journal: Clin Ophthalmol Date: 2021-01-28
Authors: Shengze Cai; He Li; Fuyin Zheng; Fang Kong; Ming Dao; George Em Karniadakis; Subra Suresh Journal: Proc Natl Acad Sci U S A Date: 2021-03-30 Impact factor: 11.205
Authors: He Li; Konstantina Sampani; Xiaoning Zheng; Dimitrios P Papageorgiou; Alireza Yazdani; Miguel O Bernabeu; George E Karniadakis; Jennifer K Sun Journal: R Soc Open Sci Date: 2020-08-26 Impact factor: 2.963